HIV infection study in Hong Kong for newly diagnosed adults
Part of Infections clinical trials.
This study looks at people newly diagnosed with HIV in Hong Kong. It aims to understand patterns of infection to improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are living with HIV
- You get care at a public HIV clinic in Hong Kong
- You are a Hong Kong resident (not just visiting or traveling)
- You are not currently in prison
- Your HIV was diagnosed in Hong Kong and you have not started treatment elsewhere
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the mental health and emotional well-being of people living with HIV. It aims to understand how they are feeling so that better support can be provided.
This trial collects blood samples from people living with HIV to study dormant (inactive) HIV cells in the lab. The goal is to better understand how to target these hidden cells as part of an eventual cure.
This study looks at how people’s immune protection after COVID-19 may change over time. It aims to better understand immunity, which could help doctors plan future care and prevention.
This study is about understanding how common Mycoplasma genitalium (a bacteria that can cause infection) is in men who have sex with men in Hong Kong. If you join, it will help doctors learn more about this infection in your community.
This study enrolls people whose HIV infection is very recent or newly diagnosed (within the last few months). The researchers want to better understand early stages of HIV to improve how doctors identify and track new infections.
This research study collects blood cells from people recently diagnosed with HIV who haven't started HIV medicines yet. Researchers use these samples to understand how HIV affects the immune system and develop better treatments.
Hear when a new HIV-1-infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.